poisar

Stocks · News reference

CNS Pharmaceuticals Q2 EPS $(0.38) Misses $(0.24) Estimate

Benzinga Newsdesk

CNS Pharmaceuticals (NASDAQ:CNSP) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of $(0.24) by 58.33 percent. This is a 94.08 percent increase over losses of $(6.42) per share

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

CNSP
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGAR

    8-K filing — CNS Pharmaceuticals, Inc. (CNSP)

    Filed: 2026-10-02 AccNo: 0001683168-26-007552 Size: 320 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits

    CNSP